U.S. flag

An official website of the United States government

NM_000454.5(SOD1):c.63C>G (p.Phe21Leu) AND Amyotrophic lateral sclerosis type 1

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Sep 26, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001065949.8

Allele description [Variation Report for NM_000454.5(SOD1):c.63C>G (p.Phe21Leu)]

NM_000454.5(SOD1):c.63C>G (p.Phe21Leu)

Genes:
SOD1-DT:SOD1 divergent transcript [Gene - HGNC]
SOD1:superoxide dismutase 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
21q22.11
Genomic location:
Preferred name:
NM_000454.5(SOD1):c.63C>G (p.Phe21Leu)
HGVS:
  • NC_000021.9:g.31659832C>G
  • NG_008689.1:g.5211C>G
  • NM_000454.5:c.63C>GMANE SELECT
  • NP_000445.1:p.Phe21Leu
  • LRG_652t1:c.63C>G
  • LRG_652:g.5211C>G
  • NC_000021.8:g.33032145C>G
  • NM_000454.4:c.63C>G
Protein change:
F21L
Links:
dbSNP: rs1555836170
NCBI 1000 Genomes Browser:
rs1555836170
Molecular consequence:
  • NM_000454.5:c.63C>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Amyotrophic lateral sclerosis type 1 (ALS1)
Synonyms:
AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL
Identifiers:
MONDO: MONDO:0007103; MedGen: C1862939; Orphanet: 803; OMIM: 105400

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001230941Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Likely pathogenic
(Sep 26, 2023)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Contribution of major amyotrophic lateral sclerosis genes to the etiology of sporadic disease.

Lattante S, Conte A, Zollino M, Luigetti M, Del Grande A, Marangi G, Romano A, Marcaccio A, Meleo E, Bisogni G, Rossini PM, Sabatelli M.

Neurology. 2012 Jul 3;79(1):66-72. doi: 10.1212/WNL.0b013e31825dceca. Epub 2012 Jun 20.

PubMed [citation]
PMID:
22722621

A neurodegenerative disease landscape of rare mutations in Colombia due to founder effects.

Acosta-Uribe J, Aguillón D, Cochran JN, Giraldo M, Madrigal L, Killingsworth BW, Singhal R, Labib S, Alzate D, Velilla L, Moreno S, García GP, Saldarriaga A, Piedrahita F, Hincapié L, López HE, Perumal N, Morelo L, Vallejo D, Solano JM, Reiman EM, Surace EI, et al.

Genome Med. 2022 Mar 8;14(1):27. doi: 10.1186/s13073-022-01035-9.

PubMed [citation]
PMID:
35260199
PMCID:
PMC8902761
See all PubMed Citations (5)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001230941.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

This sequence change replaces phenylalanine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 21 of the SOD1 protein (p.Phe21Leu). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with autosomal dominant amyotrophic lateral sclerosis and/or SOD1-related condition (PMID: 22722621, 35260199; Invitae). This variant is also known as F20L. ClinVar contains an entry for this variant (Variation ID: 859765). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SOD1 protein function. This variant disrupts the p.Phe21 amino acid residue in SOD1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 17453632, 23280792). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024